These divergent effects appear to be modulated by multiple factors, including treatment duration, drug concentration, cancer type, and patient-specific parameters such as genetic background and comorbidities [9, 19]
Native GLP-1 has been infused by the subcutaneous route (4.8 pmol/kg/min) using a portable insulin pump in a non-randomized study of subjects with type 2 diabetes over the age of 40 (mean age 55) with mean initial HbA1c of about 9%, and mean fasting glucose ~14 mM
People are embracing lifespan and healthspan enhancements and also want to look as young as they feel
And that was the first time I was able to say as an obesity medicine specialist that if I give you this drug, I can likely improve your life and reduce your chance of dying from cardiovascular disease
its about managing metabolic wellness and stabilizing healthy blood sugar levels
You still enjoy eating, but it doesnt drive behavior in the same way. That mechanism has sparked interest far beyond obesity research